Scarica l'app Stockscreener
9.17
3.02%
-0.2853
Dopo l'orario di chiusura:
9.40
0.23
+2.51%
Precedente Chiudi:
$9.4553
Aprire:
$9.13
Volume 24 ore:
32,839
Relative Volume:
1.02
Capitalizzazione di mercato:
$11.57M
Reddito:
-
Utile/perdita netta:
$-29.80M
Rapporto P/E:
-7.7059
EPS:
-1.19
Flusso di cassa netto:
$-25.19M
1 W Prestazione:
-13.16%
1M Prestazione:
-2.96%
6M Prestazione:
+13.77%
1 anno Prestazione:
-3.43%
Intervallo 1D:
$8.3312
$9.4305
Intervallo di 1 settimana:
$8.3312
$12.40
Portata 52W:
$5.00
$18.35
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Nome
Sensei Biotherapeutics Inc
Settore
Industria
Telefono
(240) 243-8000
Indirizzo
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Confronta SNSE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
9.17 | 11.93M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2021-07-01 | Downgrade | Berenberg | Buy → Hold |
| 2021-06-29 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-03-01 | Iniziato | Berenberg | Buy |
| 2021-03-01 | Iniziato | Citigroup | Buy |
| 2021-03-01 | Iniziato | Oppenheimer | Outperform |
| 2021-03-01 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Sensei Biotherapeutics Inc Borsa (SNSE) Ultime notizie
Can Sensei Biotherapeutics Inc. stock deliver consistent earnings growthWeekly Profit Analysis & Verified Swing Trading Watchlists - newser.com
How Sensei Biotherapeutics Inc. stock reacts to oil prices2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
What technical charts say about Sensei Biotherapeutics Inc. stock2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
Measuring Sensei Biotherapeutics Inc.’s beta against major indices2025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com
Long term hold vs stop loss in Sensei Biotherapeutics Inc.2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com
Applying big data sentiment scoring on Sensei Biotherapeutics Inc.Weekly Volume Report & Short-Term High Return Strategies - newser.com
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options - Stocktwits
How to build a custom watchlist for Sensei Biotherapeutics Inc.Breakout Watch & AI Based Buy/Sell Signal Reports - newser.com
Using data models to predict Sensei Biotherapeutics Inc. stock movementJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Sensei to ditch its lead candidate and cut workforce amidst strategic review - Yahoo Finance
Sensei Biotherapeutics discontinues cancer drug, explores alternatives By Investing.com - Investing.com Australia
Why hedge funds are buying Sensei Biotherapeutics Inc. stockTrade Volume Summary & Consistent Profit Alerts - newser.com
Custom strategy builders for tracking Sensei Biotherapeutics Inc.Weekly Market Report & AI Enhanced Trade Execution Alerts - newser.com
How geopolitical tensions affect Sensei Biotherapeutics Inc. stockJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
Is Sensei Biotherapeutics Inc. stock reversal real or fakeMarket Growth Review & Low Risk High Reward Ideas - newser.com
Why Sensei Biotherapeutics Inc. is moving todayWeekly Gains Report & Real-Time Market Sentiment Alerts - newser.com
Published on: 2025-10-31 04:44:02 - newser.com
Leading vs lagging indicators on Sensei Biotherapeutics Inc. performanceWeekly Risk Summary & Capital Efficient Trading Techniques - newser.com
Published on: 2025-10-31 04:26:45 - newser.com
Identifying reversal signals in Sensei Biotherapeutics Inc.2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
Can momentum traders help lift Sensei Biotherapeutics Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Published on: 2025-10-31 04:13:44 - newser.com
Is Sensei Biotherapeutics Inc. (4070) stock protected from inflationJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-31 02:55:10 - newser.com
Published on: 2025-10-31 00:46:42 - newser.com
Published on: 2025-10-31 00:27:27 - newser.com
Published on: 2025-10-31 00:24:15 - newser.com
SNSE Downgraded to Neutral by HC Wainwright & Co. Analyst Matthe - GuruFocus
Sensei Biotherapeutics stock rating downgraded as company halts key drug By Investing.com - Investing.com Canada
Sensei Biotherapeutics (SNSE) Faces Downgrade as Development Pla - GuruFocus
H.C. Wainwright downgrades Sensei on shelving of solnerstotug - TipRanks
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Sensei Biotherapeutics stock rises after announcing strategic review By Investing.com - Investing.com Philippines
Sensei Biotherapeutics stock rises after announcing strategic review - Investing.com
Sensei falls as it scraps cancer drug development, plans to sell itself - TradingView
Sensei will not initiate new clinical study for solnerstotug - TipRanks
Sensei Biotherapeutics Initiates Strategic Review to Maximize Shareholder Value - TradingView
Sensei Biotherapeutics discontinues cancer drug, explores alternatives - Investing.com
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value - The Manila Times
Sensei Biotherapeutics (NASDAQ: SNSE) discontinues solnerstotug, begins strategic review - Stock Titan
Published on: 2025-10-30 05:14:51 - newser.com
Published on: 2025-10-30 03:47:26 - newser.com
Layoff Tracker: Sensei Plans To Cut Workforce While Considering Strategic Alternatives - BioSpace
Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):